Biliary Epithelial Cells

  • Yoshiaki Mizuguchi
  • Susan Specht
  • Kumiko Isse
  • John G. LunzIII
  • Anthony J. Demetris
Part of the Molecular Pathology Library book series (MPLB, volume 5)


Biliary epithelial cells (BEC), or cholangiocytes, line a complex tree-like 3-dimensional network of conduits within the liver that form the biliary tract. The biliary tree can be divided into extrahepatic and intrahepatic components, and receives its blood supply exclusively from hepatic artery branches (Fig. 4.1) [1]. The extrahepatic biliary tract is composed of the gallbladder, common hepatic duct, common bile duct, and cystic duct [2]. The intrahepatic biliary tract contains the bile canaliculi, the canals of Hering (or intrahepatic bile ductules), interlobular bile ducts, intrahepatic bile ducts, and the left and right hepatic bile ducts [1].


Bile Duct Primary Sclerosing Cholangitis Biliary Atresia Bile Duct Ligate Keratinocyte Growth Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Bile duct ligation


Calcium/calmodulin-dependent protein kinase II


Cyclic adenosine monophosphate


Cholecystokinin B


Calcitonin gene-related peptide


Calcitonin-receptor-like receptor


cAMP response element binding


Estrogen receptor


Extracellular signal-regulated kinase


Follicle-stimulating hormone




Glycochenodeoxycholic acid


Growth hormone


Glucagon-like peptide 1


Hepatocyte growth factor


Insulin-like growth factor 1


Inositol 1,4,5-triphosphate receptor


Keratinocyte growth factor


Mitogen-activated protein kinase




Phosphoinositide 3-kinase


Protein kinase C


Peroxisome proliferatoractivated receptor-γ(gamma)


Progesterone receptor


Prolactin receptor


α(Alpha)-methyl histamine


Receptor activity-modifying protein 1


Receptor component protein


Somatostatin receptor subtype


Taurocholic acid


Taurolithocholic acid


Transforming growth factor-beta 1


UDCA conjugate tauroursodeoxycholic acid


Neurotrophic tyrosine kinase receptor type 1


Ursodeoxycholic acid


Vascular endothelial growth factor


  1. 1.
    Sherlock S, Dooley J. Diseases of the liver and biliary system. 11th ed. Malden: Blackwell Science; 2002.Google Scholar
  2. 2.
    Nakanuma Y, Hoso M, Sanzen T, Sasaki M. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. Microsc Res Tech. 1997;38(6):552–70.PubMedGoogle Scholar
  3. 3.
    Wheeler HO, Ramos OL. Determinants of the Flow and Composition of Bile in the Unanesthetized Dog During Constant Infusions of Sodium Taurocholate. J Clin Invest. 1960;39(1):161–70.PubMedGoogle Scholar
  4. 4.
    Levine RA, Hall RC. Cyclic AMP in secretin choleresis. Evidence for a regulatory role in man and baboons but not in dogs. Gastroenterology. 1976;70(4):537–44.PubMedGoogle Scholar
  5. 5.
    Marzioni M, Glaser SS, Francis H, Phinizy JL, LeSage G, Alpini G. Functional heterogeneity of cholangiocytes. Semin Liver Dis. 2002;22(3):227–40.PubMedGoogle Scholar
  6. 6.
    Kanno N, LeSage G, Glaser S, Alvaro D, Alpini G. Functional heterogeneity of the intrahepatic biliary epithelium. Hepatology. 2000;31(3):555–61.PubMedGoogle Scholar
  7. 7.
    Alpini G, McGill JM, Larusso NF. The pathobiology of biliary epithelia. Hepatology. 2002;35(5):1256–68.PubMedGoogle Scholar
  8. 8.
    Alpini G, Prall R, LaRusso N. The pathobiology of biliary epithelia. In: Arias I, Boyer J, Chisari F, editors. The liver: biology and pathobiology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 421–35.Google Scholar
  9. 9.
    Lazaridis KN, Strazzabosco M, Larusso NF. The cholangiopathies: disorders of biliary epithelia. Gastroenterology. 2004;127(5):1565–77.PubMedGoogle Scholar
  10. 10.
    Strazzabosco M, Fabris L, Spirli C. Pathophysiology of cholangiopathies. J Clin Gastroenterol. 2005;39(4 Suppl 2):S90–S102.PubMedGoogle Scholar
  11. 11.
    Strazzabosco M, Spirli C, Okolicsanyi L. Pathophysiology of the intrahepatic biliary epithelium. J Gastroenterol Hepatol. 2000;15(3):244–53.PubMedGoogle Scholar
  12. 12.
    Sakamoto T, Liu Z, Murase N, et al. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology. 1999;29(2):403–11.PubMedGoogle Scholar
  13. 13.
    Reynoso-Paz S, Coppel RL, Mackay IR, Bass NM, Ansari AA, Gershwin ME. The immunobiology of bile and biliary epithelium. Hepatology. 1999;30(2):351–7.PubMedGoogle Scholar
  14. 14.
    Ayres RC, Neuberger JM, Shaw J, Joplin R, Adams DH. Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines. Gut. 1993;34(9):1245–9.PubMedGoogle Scholar
  15. 15.
    Cerec V, Glaise D, Garnier D, et al. Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. Hepatology. 2007;45(4):957–67.PubMedGoogle Scholar
  16. 16.
    Limaye PB, Bowen WC, Orr AV, Luo J, Tseng GC, Michalopoulos GK. Mechanisms of hepatocyte growth factor-mediated and epidermal growth factor-mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium. Hepatology. 2008;47(5):1702–13.PubMedGoogle Scholar
  17. 17.
    Watanabe H, Hata M, Terada N, et al. Transdifferentiation into biliary ductular cells of hepatocytes transplanted into the spleen. Pathology. 2008;40(3):272–6.PubMedGoogle Scholar
  18. 18.
    Demetris A, Lunz III J, Subbotin V, et al. Participation of cytokines and growth factors in biliary epithelial proliferation and mito-inhibition during ductular reactions. In: Alvaro D, Marzioni M, Marzioni M, LeSage G, LaRusso N, editors. The pathophysiology of biliary epithelia. Georgetown: Landes Bioscience; 2004.Google Scholar
  19. 19.
    Cantz T, Manns MP, Ott M. Stem cells in liver regeneration and therapy. Cell Tissue Res. 2008;331(1):271–82.PubMedGoogle Scholar
  20. 20.
    Gaudio E, Carpino G, Cardinale V, Franchitto A, Onori P, Alvaro D. New insights into liver stem cells. Dig Liver Dis. 2009;41(7):455–62.PubMedGoogle Scholar
  21. 21.
    Hu M, Kurobe M, Jeong YJ, et al. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells. Gastroenterology. 2007;133(5):1579–91.PubMedGoogle Scholar
  22. 22.
    Apte U, Thompson MD, Cui S, Liu B, Cieply B, Monga SP. Wnt/beta-catenin signaling mediates oval cells response in rodents. Hepatology. 2008;47(1):288–95.PubMedGoogle Scholar
  23. 23.
    Jensen CH, Jauho EI, Santoni-Rugiu E, et al. Transit-amplifying ductular (oval) cells and their hepatocytic progeny are characterized by a novel and distinctive expression of delta-like protein/preadipocyte factor 1/fetal antigen 1. Am J Pathol. 2004;164(4):1347–59.PubMedGoogle Scholar
  24. 24.
    Limaye PB, Alarcon G, Walls AL, et al. Expression of specific hepatocyte and cholangiocyte transcription factors in human liver disease and embryonic development. Lab Invest. 2008;88(8):865–72.PubMedGoogle Scholar
  25. 25.
    Gonda TA, Tu S, Wang TC. Chronic inflammation, the tumor microenvironment and carcinogenesis. Cell Cycle. 2009;8(13):2005–13.PubMedGoogle Scholar
  26. 26.
    Bird TG, Lorenzini S, Forbes SJ. Activation of stem cells in hepatic diseases. Cell Tissue Res. 2008;331(1):283–300.PubMedGoogle Scholar
  27. 27.
    Abuladze N, Pushkin A, Tatishchev S, Newman D, Sassani P, Kurtz I. Expression and localization of rat NBC4c in liver and renal uroepithelium. Am J Physiol Cell Physiol. 2004;287(3):C781–9.PubMedGoogle Scholar
  28. 28.
    Grichtchenko II, Choi I, Zhong X, Bray-Ward P, Russell JM, Boron WF. Cloning, characterization, and chromosomal mapping of a human electroneutral Na(+)-driven Cl-HC03 exchanger. J Biol Chem. 2001;276(11):8358–63.PubMedGoogle Scholar
  29. 29.
    Strazzabosco M. New insights into cholangiocyte physiology. J Hepatol. 1997;27(5):945–52.PubMedGoogle Scholar
  30. 30.
    Alvaro D, Cho WK, Mennone A, Boyer JL. Effect of secretion on intracellular pH regulation in isolated rat bile duct epithelial cells. J Clin Invest. 1993;92(3):1314–25.PubMedGoogle Scholar
  31. 31.
    Strazzabosco M, Mennone A, Boyer JL. Intracellular pH regulation in isolated rat bile duct epithelial cells. J Clin Invest. 1991;87(5):1503–12.PubMedGoogle Scholar
  32. 32.
    Strazzabosco M, Joplin R, Zsembery A, et al. Na(+)-dependent and -independent Cl-/HCO3- exchange mediate cellular HCO3- transport in cultured human intrahepatic bile duct cells. Hepatology. 1997;25(4):976–85.PubMedGoogle Scholar
  33. 33.
    Grubman SA, Perrone RD, Lee DW, et al. Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines. Am J Physiol. 1994;266(6 Pt 1):G1060–70.PubMedGoogle Scholar
  34. 34.
    Kivela AJ, Kivela J, Saarnio J, Parkkila S. Carbonic anhydrases in normal gastrointestinal tract and gastrointestinal tumours. World J Gastroenterol. 2005;11(2):155–63.PubMedGoogle Scholar
  35. 35.
    Henry RP. Multiple roles of carbonic anhydrase in cellular transport and metabolism. Annu Rev Physiol. 1996;58:523–38.PubMedGoogle Scholar
  36. 36.
    Villanger O, Veel T, Raeder MG. Secretin causes H+ secretion from intrahepatic bile ductules by vacuolar-type H(+)-ATPase. Am J Physiol. 1993;265(4 Pt 1):G719–24.PubMedGoogle Scholar
  37. 37.
    Tietz PS, Marinelli RA, Chen XM, et al. Agonist-induced coordinated trafficking of functionally related transport proteins for water and ions in cholangiocytes. J Biol Chem. 2003;278(22):20413–9.PubMedGoogle Scholar
  38. 38.
    Marinelli RA, Tietz PS, Pham LD, Rueckert L, Agre P, LaRusso NF. Secretin induces the apical insertion of aquaporin-1 water channels in rat cholangiocytes. Am J Physiol. 1999;276(1 Pt 1):G280–6.PubMedGoogle Scholar
  39. 39.
    Tietz PS, McNiven MA, Splinter PL, Huang BQ, Larusso NF. Cytoskeletal and motor proteins facilitate trafficking of AQP1-containing vesicles in cholangiocytes. Biol Cell. 2006;98(1):43–52.PubMedGoogle Scholar
  40. 40.
    Banales JM, Arenas F, Rodriguez-Ortigosa CM, et al. Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger. Hepatology. 2006;43(2):266–75.PubMedGoogle Scholar
  41. 41.
    Spirli C, Fabris L, Duner E, et al. Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes. Gastroenterology. 2003;124(3):737–53.PubMedGoogle Scholar
  42. 42.
    Roberts SK, Kuntz SM, Gores GJ, LaRusso NF. Regulation of bicarbonate-dependent ductular bile secretion assessed by lumenal micropuncture of isolated rodent intrahepatic bile ducts. Proc Natl Acad Sci U S A. 1993;90(19):9080–4.PubMedGoogle Scholar
  43. 43.
    Mennone A, Alvaro D, Cho W, Boyer JL. Isolation of small polarized bile duct units. Proc Natl Acad Sci U S A. 1995;92(14):6527–31.PubMedGoogle Scholar
  44. 44.
    Spirli C, Granato A, Zsembery K, et al. Functional polarity of Na+/H+ and Cl/HC03 exchangers in a rat cholangiocyte cell line. Am J Physiol. 1998;275(6 Pt 1):G1236–45.PubMedGoogle Scholar
  45. 45.
    Alvaro D, Mennone A, Boyer JL. Role of kinases and phosphatases in the regulation of fluid secretion and Cl/HCO3 exchange in cholangiocytes. Am J Physiol. 1997;273(2 Pt 1):G303–13.PubMedGoogle Scholar
  46. 46.
    Basavappa S, Middleton J, Mangel AW, McGill JM, Cohn JA, Fitz JG. Cl and K+ transport in human biliary cell lines. Gastroenterology. 1993;104(6):1796–805.PubMedGoogle Scholar
  47. 47.
    McGill JM, Basavappa S, Mangel AW, Shimokura GH, Middleton JP, Fitz JG. Adenosine triphosphate activates ion permeabilities in biliary epithelial cells. Gastroenterology. 1994;107(1):236–43.PubMedGoogle Scholar
  48. 48.
    Schlenker T, Fitz JG. Ca(2+)-activated C1- channels in a human biliary cell line: regulation by Ca2+/calmodulin-dependent protein kinase. Am J Physiol. 1996;271(2 Pt 1):G304–10.PubMedGoogle Scholar
  49. 49.
    Clarke LL, Harline MC, Gawenis LR, Walker NM, Turner JT, Weisman GA. Extracellular UTP stimulates electrogenic bicarbonate secretion across CFTR knockout gallbladder epithelium. Am J Physiol Gastrointest Liver Physiol. 2000;279(1):G132–8.PubMedGoogle Scholar
  50. 50.
    Feranchak AP, Doctor RB, Troetsch M, Brookman K, Johnson SM, Fitz JG. Calcium-dependent regulation of secretion in biliary epithelial cells: the role of apamin-sensitive SK channels. Gastroenterology. 2004;127(3):903–13.PubMedGoogle Scholar
  51. 51.
    Singh SK, Mennone A, Gigliozzi A, Fraioli F, Boyer JL. Cl(-)-dependent secretory mechanisms in isolated rat bile duct epithelial units. Am J Physiol Gastrointest Liver Physiol. 2001;281(2):G438–46.PubMedGoogle Scholar
  52. 52.
    Scoazec JY, Bringuier AF, Medina JF, et al. The plasma membrane polarity of human biliary epithelial cells: in situ immunohistochemical analysis and functional implications. J Hepatol. 1997;26(3):543–53.PubMedGoogle Scholar
  53. 53.
    Hammerton RW, Krzeminski KA, Mays RW, Ryan TA, Wollner DA, Nelson WJ. Mechanism for regulating cell surface distribution of Na+, K(+)-ATPase in polarized epithelial cells. Science. 1991;254(5033):847–50.PubMedGoogle Scholar
  54. 54.
    Rakowski RF, Gadsby DC, De Weer P. Stoichiometry and voltage dependence of the sodium pump in voltage-clamped, internally dialyzed squid giant axon. J Gen Physiol. 1989;93(5):903–41.PubMedGoogle Scholar
  55. 55.
    Roman R, Feranchak AP, Troetsch M, et al. Molecular characterization of volume-sensitive SK(Ca) channels in human liver cell lines. Am J Physiol Gastrointest Liver Physiol. 2002;282(1):G116–22.PubMedGoogle Scholar
  56. 56.
    McRoberts JA, Beuerlein G, Dharmsathaphorn K. Cyclic AMP and Ca2+-activated K+ transport in a human colonic epithelial cell line. J Biol Chem. 1985;260(26):14163–72.PubMedGoogle Scholar
  57. 57.
    Marinelli RA, Pham LD, Tietz PS, LaRusso NF. Expression of aquaporin-4 water channels in rat cholangiocytes. Hepatology. 2000;31(6):1313–7.PubMedGoogle Scholar
  58. 58.
    Splinter PL, Masyuk AI, Marinelli RA, LaRusso NF. AQP4 transfected into mouse cholangiocytes promotes water transport in biliary epithelia. Hepatology. 2004;39(1):109–16.PubMedGoogle Scholar
  59. 59.
    Lazaridis KN, Pham L, Tietz P, et al. Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter. J Clin Invest. 1997;100(11):2714–21.PubMedGoogle Scholar
  60. 60.
    Alpini G, Glaser SS, Rodgers R, et al. Functional expression of the apical Na+-dependent bile acid transporter in large but not small rat cholangiocytes. Gastroenterology. 1997;113(5):1734–40.PubMedGoogle Scholar
  61. 61.
    Alpini G, Glaser SS, Ueno Y, et al. Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. Gastroenterology. 1999;116(1):179–86.PubMedGoogle Scholar
  62. 62.
    Alpini G, Glaser S, Baiocchi L, Francis H, Xia X, Lesage G. Secretin activation of the apical Na+-dependent bile acid transporter is associated with cholehepatic shunting in rats. Hepatology. 2005;41(5):1037–45.PubMedGoogle Scholar
  63. 63.
    Lazaridis KN, Tietz P, Wu T, Kip S, Dawson PA, LaRusso NF. Alternative splicing of the rat sodium/bile acid transporter changes its cellular localization and transport properties. Proc Natl Acad Sci U S A. 2000;97(20):11092–7.PubMedGoogle Scholar
  64. 64.
    Kanno N, LeSage G, Glaser S, Alpini G. Regulation of cholangiocyte bicarbonate secretion. Am J Physiol Gastrointest Liver Physiol. 2001;281(3):G612–25.PubMedGoogle Scholar
  65. 65.
    Nyberg B, Einarsson K, Sonnenfeld T. Evidence that vasoactive intestinal peptide induces ductular secretion of bile in humans. Gastroenterology. 1989;96(3):920–4.PubMedGoogle Scholar
  66. 66.
    Farouk M, Vigna SR, McVey DC, Meyers WC. Localization and characterization of secretin binding sites expressed by rat bile duct epithelium. Gastroenterology. 1992;102(3):963–8.PubMedGoogle Scholar
  67. 67.
    Farouk M, Vigna SR, Haebig JE, et al. Secretin receptors in a new preparation of plasma membranes from intrahepatic biliary epithelium. J Surg Res. 1993;54(1):1–6.PubMedGoogle Scholar
  68. 68.
    Lenzen R, Alpini G, Tavoloni N. Secretin stimulates bile ductular secretory activity through the cAMP system. Am J Physiol. 1992;263(4 Pt 1):G527–32.PubMedGoogle Scholar
  69. 69.
    Lenzen R, Elster J, Behrend C, Hampel KE, Bechstein WO, Neuhaus P. Bile acid-independent bile flow is differently regulated by glucagon and secretin in humans after orthotopic liver transplantation. Hepatology. 1997;26(5):1272–81.PubMedGoogle Scholar
  70. 70.
    Holtmann MH, Ganguli S, Hadac EM, Dolu V, Miller LJ. Multiple extracellular loop domains contribute critical determinants for agonist binding and activation of the secretin receptor. J Biol Chem. 1996;271(25):14944–9.PubMedGoogle Scholar
  71. 71.
    Pang RT, Ng SS, Cheng CH, Holtmann MH, Miller LJ, Chow BK. Role of N-linked glycosylation on the function and expression of the human secretin receptor. Endocrinology. 1999;140(11):5102–11.PubMedGoogle Scholar
  72. 72.
    Gardner D and Jensen R.T. Regulation of pancreatic enzyme secretion in vitro. (6th edition). In: Johnson LR, Christensen J, Grossman MI, Jacobsen ED, Schutz SG, editors. Physiology of the gastrointestinal tract. vol. 2 Raven Press, New York, NY; 1981;(2):831–871.Google Scholar
  73. 73.
    Nyberg B, Sonnenfeld T, Einarsson K. Vasoactive intestinal peptide and secretin: effects of combined and separate intravenous infusions on bile secretion in man. Scand J Gastroenterol. 1991;26(1):109–18.PubMedGoogle Scholar
  74. 74.
    Kaminski DL, Deshpande YG. Effect of somatostatin and bombesin on secretin-stimulated ductular bile flow in dogs. Gastroenterology. 1983;85(6):1239–47.PubMedGoogle Scholar
  75. 75.
    Kortz WJ, Nashold JR, Delong E, Meyers WC. Effects of bombesin on fasting bile formation. Ann Surg. 1986;203(1):1–7.PubMedGoogle Scholar
  76. 76.
    Cho WK, Mennone A, Rydberg SA, Boyer JL. Bombesin stimulates bicarbonate secretion from rat cholangiocytes: implications for neural regulation of bile secretion. Gastroenterology. 1997;113(1):311–21.PubMedGoogle Scholar
  77. 77.
    Cho WK, Boyer JL. Characterization of ion transport mechanisms involved in bombesin-stimulated biliary secretion in rat cholangiocytes. J Hepatol. 1999;30(6):1045–51.PubMedGoogle Scholar
  78. 78.
    Cho WK, Boyer JL. Vasoactive intestinal polypeptide is a potent regulator of bile secretion from rat cholangiocytes. Gastroenterology. 1999;117(2):420–8.PubMedGoogle Scholar
  79. 79.
    Alpini G, Glaser SS, Ueno Y, et al. Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation. Am J Physiol. 1998;274(4 Pt 1):G767–75.PubMedGoogle Scholar
  80. 80.
    Tietz PS, Alpini G, Pham LD, Larusso NF. Somatostatin inhibits secretin-induced ductal hypercholeresis and exocytosis by cholangiocytes. Am J Physiol. 1995;269(1 Pt 1):G110–8.PubMedGoogle Scholar
  81. 81.
    Glaser SS, Rodgers RE, Phinizy JL, et al. Gastrin inhibits secretin-induced ductal secretion by interaction with specific receptors on rat cholangiocytes. Am J Physiol. 1997;273(5 Pt 1):G1061–70.PubMedGoogle Scholar
  82. 82.
    Nathanson MH, Burgstahler AD, Mennone A, Boyer JL. Characterization of cytosolic Ca2+ signaling in rat bile duct epithelia. Am J Physiol. 1996;271(1 Pt 1):G86–96.PubMedGoogle Scholar
  83. 83.
    Alvaro D, Alpini G, Jezequel AM, et al. Role and mechanisms of action of acetylcholine in the regulation of rat cholangiocyte secretory functions. J Clin Invest. 1997;100(6):1349–62.PubMedGoogle Scholar
  84. 84.
    Glaser S, Alvaro D, Roskams T, et al. Dopaminergic inhibition of secretin-stimulated choleresis by increased PKC-gamma expression and decrease of PKA activity. Am J Physiol Gastrointest Liver Physiol. 2003;284(4):G683–94.PubMedGoogle Scholar
  85. 85.
    LeSage GD, Alvaro D, Glaser S, et al. Alpha-1 adrenergic receptor agonists modulate ductal secretion of BDL rats via Ca(2+)- and PKC-dependent stimulation of cAMP. Hepatology. 2004;40(5):1116–27.PubMedGoogle Scholar
  86. 86.
    Minagawa N, Nagata J, Shibao K, et al. Cyclic AMP regulates bicarbonate secretion in cholangiocytes through release of ATP into bile. Gastroenterology. 2007;133(5):1592–602.PubMedGoogle Scholar
  87. 87.
    Fiorotto R, Spirli C, Fabris L, Cadamuro M, Okolicsanyi L, Strazzabosco M. Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. Gastroenterology. 2007;133(5):1603–13.PubMedGoogle Scholar
  88. 88.
    Roman RM, Fitz JG. Emerging roles of purinergic signaling in gastrointestinal epithelial secretion and hepatobiliary function. Gastroenterology. 1999;116(4):964–79.PubMedGoogle Scholar
  89. 89.
    Feranchak AP, Fitz JG. Adenosine triphosphate release and purinergic regulation of cholangiocyte transport. Semin Liver Dis. 2002;22(3):251–62.PubMedGoogle Scholar
  90. 90.
    Bucheimer RE, Linden J. Purinergic regulation of epithelial transport. J Physiol. 2004;555(Pt 2):311–21.PubMedGoogle Scholar
  91. 91.
    Dranoff JA, Nathanson MH. It’s swell to have ATP in the liver. J Hepatol. 2000;33(2):323–5.PubMedGoogle Scholar
  92. 92.
    Dranoff J. Purinergic regulation of bile ductular secretion. In: Alpini G, Alvaro D, Marzioni M, LeSage G, LaRusso N, editors. The pathophysiology of the biliary epithelia. Georgetown, TX: Landes Bioscience; 2004. p. 96–104.Google Scholar
  93. 93.
    Leipziger J. Control of epithelial transport via luminal P2 receptors. Am J Physiol Renal Physiol. 2003;284(3):F419–32.PubMedGoogle Scholar
  94. 94.
    Zsembery A, Spirli C, Granato A, et al. Purinergic regulation of acid/base transport in human and rat biliary epithelial cell lines. Hepatology. 1998;28(4):914–20.PubMedGoogle Scholar
  95. 95.
    Huang BQ, Masyuk TV, Muff MA, Tietz PS, Masyuk AI, Larusso NF. Isolation and characterization of cholangiocyte primary cilia. Am J Physiol Gastrointest Liver Physiol. 2006;291(3):G500–9.PubMedGoogle Scholar
  96. 96.
    Masyuk AI, Masyuk TV, Splinter PL, Huang BQ, Stroope AJ, LaRusso NF. Cholangiocyte cilia detect changes in luminal fluid flow and transmit them into intracellular Ca2+ and cAMP signaling. Gastroenterology. 2006;131(3):911–20.PubMedGoogle Scholar
  97. 97.
    Gradilone SA, Masyuk AI, Splinter PL, et al. Cholangiocyte cilia express TRPV4 and detect changes in luminal tonicity inducing bicarbonate secretion. Proc Natl Acad Sci U S A. 2007;104(48):19138–43.PubMedGoogle Scholar
  98. 98.
    Masyuk A, Gradilone S, Banales J, et al. Cholangiocyte primary cilia function as chemosensory organelles. J Am Soc Nephrol. 2007;18:132A.Google Scholar
  99. 99.
    Nauli SM, Alenghat FJ, Luo Y, et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet. 2003;33(2):129–37.PubMedGoogle Scholar
  100. 100.
    Masyuk TV, Huang BQ, Ward CJ, et al. Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat. Gastroenterology. 2003;125(5):1303–10.PubMedGoogle Scholar
  101. 101.
    Tsukahara A, Seki S, Iiai T, et al. Mouse liver T cells: their change with aging and in comparison with peripheral T cells. Hepatology. 1997;26(2):301–9.PubMedGoogle Scholar
  102. 102.
    Naito M, Hasegawa G, Ebe Y, Yamamoto T. Differentiation and function of Kupffer cells. Med Electron Microsc. 2004;37(1):16–28.PubMedGoogle Scholar
  103. 103.
    Demetris A. Immunopathology of the Human Biliary Tree. In: Sirica A, Longnecker D, editors. Biliary and pancreatic ductal epithelia. New York: Marcel Dekker; 1997. p. 127–80.Google Scholar
  104. 104.
    Dillon PW, Belchis D, Minnick K, Tracy T. Differential expression of the major histocompatibility antigens and ICAM-1 on bile duct epithelial cells in biliary atresia. Tohoku J Exp Med. 1997;181(1):33–40.PubMedGoogle Scholar
  105. 105.
    Saidman SL, Duquesnoy RJ, Zeevi A, Fung JJ, Starzl TE, Demetris AJ. Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes. Hepatology. 1991;13(2):239–46.PubMedGoogle Scholar
  106. 106.
    Hreha G, Jefferson DM, Yu CH, et al. Immortalized intrahepatic mouse biliary epithelial cells: immunologic characterization and immunogenicity. Hepatology. 1999;30(2):358–71.PubMedGoogle Scholar
  107. 107.
    Himeno H, Saibara T, Onishi S, Yamamoto Y, Enzan H. Administration of interleukin-2 induces major histocompatibility complex class II expression on the biliary epithelial cells, possibly through endogenous interferon-gamma production. Hepatology. 1992;16(2):409–17.PubMedGoogle Scholar
  108. 108.
    Markus BH, Duquesnoy RJ, Blaheta RA, Scholz M, Encke A. Role of HLA antigens in liver transplantation with special reference to cellular immune reactions. Langenbecks Arch Surg. 1998;383(1):87–94.PubMedGoogle Scholar
  109. 109.
    Tsuneyama K, Harada K, Yasoshima M, Kaji K, Gershwin ME, Nakanuma Y. Expression of co-stimulatory factor B7–2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: an immunohistochemical study. J Pathol. 1998;186(2):126–30.PubMedGoogle Scholar
  110. 110.
    Dong H, Chen X. Immunoregulatory role of B7-H1 in chronicity of inflammatory responses. Cell Mol Immunol. 2006;3(3):179–87.PubMedGoogle Scholar
  111. 111.
    Leon MP, Bassendine MF, Wilson JL, Ali S, Thick M, Kirby JA. Immunogenicity of biliary epithelium: investigation of antigen presentation to CD4+ T cells. Hepatology. 1996;24(3):561–7.PubMedGoogle Scholar
  112. 112.
    Selmi C, Lleo A, Pasini S, Zuin M, Gershwin ME. Innate immunity and primary biliary cirrhosis. Curr Mol Med. 2009;9(1):45–51.PubMedGoogle Scholar
  113. 113.
    Barnes BH, Tucker RM, Wehrmann F, Mack DG, Ueno Y, Mack CL. Cholangiocytes as immune modulators in rotavirus-induced murine biliary atresia. Liver Int. 2009;29(8):1253–61.PubMedGoogle Scholar
  114. 114.
    Lombardi G, Sidhu S, Batchelor R, Lechler R. Anergic T cells as suppressor cells in vitro. Science. 1994;264(5165):1587–9.PubMedGoogle Scholar
  115. 115.
    Savage CO, Brooks CJ, Harcourt GC, et al. Human vascular endothelial cells process and present autoantigen to human T cell lines. Int Immunol. 1995;7(3):471–9.PubMedGoogle Scholar
  116. 116.
    Leon MP, Kirby JA, Gibbs P, Burt AD, Bassendine MF. Immunogenicity of biliary epithelial cells: study of the expression of B7 molecules. J Hepatol. 1995;22(5):591–5.PubMedGoogle Scholar
  117. 117.
    Morita M, Watanabe Y, Akaike T. Inflammatory cytokines up-regulate intercellular adhesion molecule-1 expression on primary cultured mouse hepatocytes and T-lymphocyte adhesion. Hepatology. 1994;19(2):426–31.PubMedGoogle Scholar
  118. 118.
    Van Den Heuvel MC, Slooff MJ, Visser L, et al. Expression of anti-OV6 antibody and anti-N-CAM antibody along the biliary line of normal and diseased human livers. Hepatology. 2001;33(6):1387–93.Google Scholar
  119. 119.
    Yang L, Froio RM, Sciuto TE, Dvorak AM, Alon R, Luscinskas FW. ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow. Blood. 2005;106(2):584–92.PubMedGoogle Scholar
  120. 120.
    Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol. 1995;57:827–72.PubMedGoogle Scholar
  121. 121.
    Leon MP, Bassendine MF, Gibbs P, Thick M, Kirby JA. Immunogenicity of biliary epithelium: study of the adhesive interaction with lymphocytes. Gastroenterology. 1997;112(3):968–77.PubMedGoogle Scholar
  122. 122.
    Cruickshank SM, Southgate J, Selby PJ, Trejdosiewicz LK. Expression and cytokine regulation of immune recognition elements by normal human biliary epithelial and established liver cell lines in vitro. J Hepatol. 1998;29(4):550–8.PubMedGoogle Scholar
  123. 123.
    Morland CM, Fear J, McNab G, Joplin R, Adams DH. Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro. Proc Assoc Am Physicians. 1997;109(4):372–82.PubMedGoogle Scholar
  124. 124.
    Yokoyama T, Komori A, Nakamura M, et al. Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways. Liver Int. 2006;26(4):467–76.PubMedGoogle Scholar
  125. 125.
    Yasoshima M, Kono N, Sugawara H, Katayanagi K, Harada K, Nakanuma Y. Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: in situ and culture study. Lab Invest. 1998;78(1):89–100.PubMedGoogle Scholar
  126. 126.
    Matsumoto K, Fujii H, Michalopoulos G, Fung JJ, Demetris AJ. Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro. Hepatology. 1994;20(2):376–82.PubMedGoogle Scholar
  127. 127.
    Demetris AJ, Lunz 3rd JG, Specht S, Nozaki I. Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease. World J Gastroenterol. 2006;12(22):3512–22.PubMedGoogle Scholar
  128. 128.
    Fava G, Glaser S, Francis H, Alpini G. The immunophysiology of biliary epithelium. Semin Liver Dis. 2005;25(3):251–64.PubMedGoogle Scholar
  129. 129.
    Torok N, Gores G. Apoptosis of biliary epithelial cells. In: Alpini G, Alvaro D, Marzioni M, LeSage G, LaRusso N, editors. The pathophysiology of biliary epithelia. Georgetown, TX: Landes Bioscience; 2004.Google Scholar
  130. 130.
    Ueno Y, Ishii M, Yahagi K, et al. Fas-mediated cholangiopathy in the murine model of graft versus host disease. Hepatology. 2000;31(4):966–74.PubMedGoogle Scholar
  131. 131.
    Ahn EY, Pan G, Vickers SM, McDonald JM. IFN-gammaupregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma. Int J Cancer. 2002;100(4):445–51.PubMedGoogle Scholar
  132. 132.
    Gapany C, Zhao M, Zimmermann A. The apoptosis protector, bcl-2 protein, is downregulated in bile duct epithelial cells of human liver allografts. J Hepatol. 1997;26(3):535–42.PubMedGoogle Scholar
  133. 133.
    Afford SC, Ahmed-Choudhury J, Randhawa S, et al. CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells. FASEB J. 2001;15(13):2345–54.PubMedGoogle Scholar
  134. 134.
    Utaisincharoen P, Tangthawornchaikul N, Ubol S, Chaisuriya P, Sirisinha S. TNF-alpha induces caspase 3 (CPP 32) dependent apoptosis in human cholangiocarcinoma cell line. Southeast Asian J Trop Med Public Health. 2000;31 Suppl 1:167–70.PubMedGoogle Scholar
  135. 135.
    Gong AY, Zhou R, Hu G, et al. MicroRNA-513 regulates B7-H1 translation and is involved in IFN-gamma-induced B7-H1 expression in cholangiocytes. J Immunol. 2009;182(3):1325–33.PubMedGoogle Scholar
  136. 136.
    Takeda K, Kojima Y, Ikejima K, et al. Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease. Proc Natl Acad Sci U S A. 2008;105(31):10895–900.PubMedGoogle Scholar
  137. 137.
    Charlotte F, L’Hermine A, Martin N, et al. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am J Pathol. 1994;144(3):460–5.PubMedGoogle Scholar
  138. 138.
    Celli A, Que FG, Gores GJ, LaRusso NF. Glutathione depletion is associated with decreased Bcl-2 expression and increased apoptosis in cholangiocytes. Am J Physiol. 1998;275(4 Pt 1):G749–57.PubMedGoogle Scholar
  139. 139.
    Stohs SJ. The role of free radicals in toxicity and disease. J Basic Clin Physiol Pharmacol. 1995;6(3–4):205–28.PubMedGoogle Scholar
  140. 140.
    Miesel R, Sanocka D, Kurpisz M, Kroger H. Antiinflammatory effects of NADPH oxidase inhibitors. Inflammation. 1995;19(3):347–62.PubMedGoogle Scholar
  141. 141.
    Sakaguchi S, Furusawa S, Yokota K, Sasaki K, Takayanagi M, Takayanagi Y. The enhancing effect of tumour necrosis factor-alpha on oxidative stress in endotoxemia. Pharmacol Toxicol. 1996;79(5):259–65.PubMedGoogle Scholar
  142. 142.
    Wang JH, Redmond HP, Watson RW, Bouchier-Hayes D. Induction of human endothelial cell apoptosis requires both heat shock and oxidative stress responses. Am J Physiol. 1997;272(5 Pt 1):C1543–51.PubMedGoogle Scholar
  143. 143.
    Jaiswal M, LaRusso NF, Shapiro RA, Billiar TR, Gores GJ. Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. Gastroenterology. 2001;120(1):190–9.PubMedGoogle Scholar
  144. 144.
    Poli G. Liver damage due to free radicals. Br Med Bull. 1993;49(3):604–20.PubMedGoogle Scholar
  145. 145.
    Farinati F, Cardin R, de Maria N, et al. Zinc, iron, and peroxidation in liver tissue. Cumulative effects of alcohol consumption and virus-mediated damage – a preliminary report. Biol Trace Elem Res. 1995;47(1–3):193–9.PubMedGoogle Scholar
  146. 146.
    Salunga TL, Cui ZG, Shimoda S, et al. Oxidative stress-induced apoptosis of bile duct cells in primary biliary cirrhosis. J Autoimmun. 2007;29(2–3):78–86.PubMedGoogle Scholar
  147. 147.
    Tsuneyama K, Harada K, Kono N, et al. Damaged interlobular bile ducts in primary biliary cirrhosis show reduced expression of glutathione-S-transferase-pi and aberrant expression of 4-hydroxynonenal. J Hepatol. 2002;37(2):176–83.PubMedGoogle Scholar
  148. 148.
    Salas JT, Banales JM, Sarvide S, et al. Ae2a, b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology. 2008;134(5):1482–93.PubMedGoogle Scholar
  149. 149.
    Henrion-Caude A, Flamant C, Roussey M, et al. Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism. Hepatology. 2002;36(4 Pt 1):913–7.PubMedGoogle Scholar
  150. 150.
    Demetris AJ, Specht S, Nozaki I, et al. Small proline-rich proteins (SPRR) function as SH3 domain ligands, increase resistance to injury and are associated with epithelial-mesenchymal transition (EMT) in cholangiocytes. J Hepatol. 2008;48(2):276–88.PubMedGoogle Scholar
  151. 151.
    Collado M, Gil J, Efeyan A, et al. Tumour biology: senescence in premalignant tumours. Nature. 2005;436(7051):642.PubMedGoogle Scholar
  152. 152.
    Harada K, Furubo S, Ozaki S, Hiramatsu K, Sudo Y, Nakanuma Y. Increased expression of WAF1 in intrahepatic bile ducts in primary biliary cirrhosis relates to apoptosis. J Hepatol. 2001;34(4):500–6.PubMedGoogle Scholar
  153. 153.
    Lunz 3rd JG, Contrucci S, Ruppert K, et al. Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. Am J Pathol. 2001;158(4):1379–90.PubMedGoogle Scholar
  154. 154.
    Sasaki M, Ikeda H, Sato Y, Nakanuma Y. Proinflammatory cytokine-induced cellular senescence of biliary epithelial cells is mediated via oxidative stress and activation of ATM pathway: a culture study. Free Radic Res. 2008;42(7):625–32.PubMedGoogle Scholar
  155. 155.
    Sasaki M, Ikeda H, Sato Y, Nakanuma Y. Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis. Am J Pathol. 2006;169(3):831–45.PubMedGoogle Scholar
  156. 156.
    Sasaki M, Yamaguchi J, Itatsu K, Ikeda H, Nakanuma Y. Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis. J Pathol. 2008;215(2):175–83.PubMedGoogle Scholar
  157. 157.
    Sasaki M, Yamaguchi J, Ikeda H, Itatsu K, Nakanuma Y. Polycomb group protein Bmi1 is overexpressed and essential in anchorage-independent colony formation, cell proliferation and repression of cellular senescence in cholangiocarcinoma: tissue and culture studies. Hum Pathol. 2009;40:1723–30.PubMedGoogle Scholar
  158. 158.
    Cabral A, Voskamp P, Cleton-Jansen AM, South A, Nizetic D, Backendorf C. Structural organization and regulation of the small proline-rich family of cornified envelope precursors suggest a role in adaptive barrier function. J Biol Chem. 2001;276(22):19231–7.PubMedGoogle Scholar
  159. 159.
    Patel S, Kartasova T, Segre JA. Mouse Sprr locus: a tandem array of coordinately regulated genes. Mamm Genome. 2003;14(2):140–8.PubMedGoogle Scholar
  160. 160.
    Elder JT, Zhao X. Evidence for local control of gene expression in the epidermal differentiation complex. Exp Dermatol. 2002;11(5):406–12.PubMedGoogle Scholar
  161. 161.
    Tarcsa E, Candi E, Kartasova T, Idler WW, Marekov LN, Steinert PM. Structural and transglutaminase substrate properties of the small proline-rich 2 family of cornified cell envelope proteins. J Biol Chem. 1998;273(36):23297–303.PubMedGoogle Scholar
  162. 162.
    Nozaki I, Lunz 3rd JG, Specht S, et al. Small proline-rich proteins 2 are noncoordinately upregulated by IL-6/STAT3 signaling after bile duct ligation. Lab Invest. 2005;85(1):109–23.PubMedGoogle Scholar
  163. 163.
    Manning RJ, Walker PG, Carter L, Barrington PJ, Jackson GD. Studies on the origins of biliary immunoglobulins in rats. Gastroenterology. 1984;87(1):173–9.PubMedGoogle Scholar
  164. 164.
    Jackson GD, Walker PG. The transient appearance of IgM antibodies in the bile of rats injected with Salmonella enteritidis. Immunol Lett. 1983;7(1):41–5.PubMedGoogle Scholar
  165. 165.
    Nagura H, Smith PD, Nakane PK, Brown WR. IGA in human bile and liver. J Immunol. 1981;126(2):587–95.PubMedGoogle Scholar
  166. 166.
    Phalipon A, Cardona A, Kraehenbuhl JP, Edelman L, Sansonetti PJ, Corthesy B. Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity. 2002;17(1):107–15.PubMedGoogle Scholar
  167. 167.
    Delacroix DL, Courtoy PJ, Rahier J, Reynaert M, Vaerman JP, Dive C. Localization and serum concentration of secretory component during massive necrosis of human liver. Gastroenterology. 1984;86(3):521–31.PubMedGoogle Scholar
  168. 168.
    Daniels CK, Schmucker DL. Secretory component-dependent binding of immunoglobulin A in the rat, monkey and human: a comparison of intestine and liver. Hepatology. 1987;7(3):517–21.PubMedGoogle Scholar
  169. 169.
    Aagaard BD, Heyworth MF, Oesterle AL, Jones AL, Way LW. Intestinal immunisation with Escherichia coli protects rats against Escherichia coli induced cholangitis. Gut. 1996;39(1):136–40.PubMedGoogle Scholar
  170. 170.
    Harmatz PR, Kleinman RE, Bunnell BW, Bloch KJ, Walker WA. Hepatobiliary clearance of IgA immune complexes formed in the circulation. Hepatology. 1982;2(3):328–33.PubMedGoogle Scholar
  171. 171.
    Peppard JV, Orlans E, Andrew E, Payne AW. Elimination into bile of circulating antigen by endogenous IgA antibody in rats. Immunology. 1982;45(3):467–72.PubMedGoogle Scholar
  172. 172.
    Mostov KE. Transepithelial transport of immunoglobulins. Annu Rev Immunol. 1994;12:63–84.PubMedGoogle Scholar
  173. 173.
    Saito K, Nakanuma Y. Lactoferrin and lysozyme in the intrahepatic bile duct of normal livers and hepatolithiasis. An immunohistochemical study. J Hepatol. 1992;15(1–2):147–53.PubMedGoogle Scholar
  174. 174.
    Chen XM, O’Hara SP, Nelson JB, et al. Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB. J Immunol. 2005;175(11):7447–56.PubMedGoogle Scholar
  175. 175.
    Harada K, Ohira S, Isse K, et al. Lipopolysaccharide activates nuclear factor-kappaB through toll-like receptors and related molecules in cultured biliary epithelial cells. Lab Invest. 2003;83(11):1657–67.PubMedGoogle Scholar
  176. 176.
    Fellermann K, Stange EF. Defensins – innate immunity at the epithelial frontier. Eur J Gastroenterol Hepatol. 2001;13(7):771–6.PubMedGoogle Scholar
  177. 177.
    Taylor K, Barran PE, Dorin JR. Structure-activity relationships in beta-defensin peptides. Biopolymers. 2008;90(1):1–7.PubMedGoogle Scholar
  178. 178.
    Harada K, Ohba K, Ozaki S, et al. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree. Hepatology. 2004;40(4):925–32.PubMedGoogle Scholar
  179. 179.
    D’Aldebert E, Biyeyeme Bi Mve MJ, Mergey M, et al. Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium. Gastroenterology. 2009;136(4):1435–43.PubMedGoogle Scholar
  180. 180.
    Haller O, Kochs G. Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity. Traffic. 2002;3(10):710–7.PubMedGoogle Scholar
  181. 181.
    Al-Masri AN, Flemming P, Rodeck B, Melter M, Leonhardt J, Petersen C. Expression of the interferon-induced Mx proteins in biliary atresia. J Pediatr Surg. 2006;41(6):1139–43.PubMedGoogle Scholar
  182. 182.
    Huang YH, Chou MH, Du YY, et al. Expression of toll-like receptors and type 1 interferon specific protein MxA in biliary atresia. Lab Invest. 2007;87(1):66–74.PubMedGoogle Scholar
  183. 183.
    Harada K, Sato Y, Itatsu K, et al. Innate immune response to double-stranded RNA in biliary epithelial cells is associated with the pathogenesis of biliary atresia. Hepatology. 2007;46(4):1146–54.PubMedGoogle Scholar
  184. 184.
    Mashimo H, Wu DC, Podolsky DK, Fishman MC. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 1996;274(5285):262–5.PubMedGoogle Scholar
  185. 185.
    Tomasetto C, Masson R, Linares JL, et al. pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology. 2000;118(1):70–80.PubMedGoogle Scholar
  186. 186.
    Kindon H, Pothoulakis C, Thim L, Lynch-Devaney K, Podolsky DK. Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology. 1995;109(2):516–23.PubMedGoogle Scholar
  187. 187.
    Kanai M, Mullen C, Podolsky DK. Intestinal trefoil factor induces inactivation of extracellular signal-regulated protein kinase in intestinal epithelial cells. Proc Natl Acad Sci U S A. 1998;95(1):178–82.PubMedGoogle Scholar
  188. 188.
    Podolsky DK, Lynch-Devaney K, Stow JL, et al. Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem. 1993;268(9):6694–702.PubMedGoogle Scholar
  189. 189.
    Nozaki I, Lunz 3rd JG, Specht S, et al. Regulation and function of trefoil factor family 3 expression in the biliary tree. Am J Pathol. 2004;165(6):1907–20.PubMedGoogle Scholar
  190. 190.
    Sasaki M, Tsuneyama K, Saito T, et al. Site-characteristic expression and induction of trefoil factor family 1, 2 and 3 and malignant brain tumor-1 in normal and diseased intrahepatic bile ducts relates to biliary pathophysiology. Liver Int. 2004;24(1):29–37.PubMedGoogle Scholar
  191. 191.
    Sasaki M, Tsuneyama K, Nakanuma Y. Aberrant expression of trefoil factor family 1 in biliary epithelium in hepatolithiasis and cholangiocarcinoma. Lab Invest. 2003;83(10):1403–13.PubMedGoogle Scholar
  192. 192.
    Srivatsa G, Giraud AS, Ulaganathan M, Yeomans ND, Dow C, Nicoll AJ. Biliary epithelial trefoil peptide expression is increased in biliary diseases. Histopathology. 2002;40(3):261–8.PubMedGoogle Scholar
  193. 193.
    Tebbutt NC, Giraud AS, Inglese M, et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat Med. 2002;8(10):1089–97.PubMedGoogle Scholar
  194. 194.
    Alvaro D, Mancino MG, Glaser S, et al. Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology. 2007;132(1):415–31.PubMedGoogle Scholar
  195. 195.
    Gaudio E, Onori P, Franchitto A, et al. Vascularization of the intrahepatic biliary tree and its role in the regulation of cholangiocyte growth. In: Alpini G, Alvaro D, LeSage G, Marzioni M, LaRusso N, editors. The pathophysiology of biliary epithelia. Georgetown, TX: Landes Biosciences; 2004. p. 41–5.Google Scholar
  196. 196.
    Alvaro D, Metalli VD, Alpini G, et al. The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis. J Hepatol. 2005;43(5):875–83.PubMedGoogle Scholar
  197. 197.
    Gaudio E, Barbaro B, Alvaro D, et al. Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. Gastroenterology. 2006;130(4):1270–82.PubMedGoogle Scholar
  198. 198.
    Grappone C, Pinzani M, Parola M, et al. Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats. J Hepatol. 1999;31(1):100–9.PubMedGoogle Scholar
  199. 199.
    Cramer T, Schuppan D, Bauer M, Pfander D, Neuhaus P, Herbst H. Hepatocyte growth factor and c-Met expression in rat and human liver fibrosis. Liver Int. 2004;24(4):335–44.PubMedGoogle Scholar
  200. 200.
    Luo B, Tang L, Wang Z, et al. Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome. Gastroenterology. 2005;129(2):682–95.PubMedGoogle Scholar
  201. 201.
    Sirica AE, Elmore LW, Sano N. Characterization of rat hyperplastic bile ductular epithelial cells in culture and in vivo. Dig Dis Sci. 1991;36(4):494–501.PubMedGoogle Scholar
  202. 202.
    Ingber DE, Dike L, Hansen L, et al. Cellular tensegrity: exploring how mechanical changes in the cytoskeleton regulate cell growth, migration, and tissue pattern during morphogenesis. Int Rev Cytol. 1994;150:173–224.PubMedGoogle Scholar
  203. 203.
    Jhandier MN, Kruglov EA, Lavoie EG, Sevigny J, Dranoff JA. Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2. J Biol Chem. 2005;280(24):22986–92.PubMedGoogle Scholar
  204. 204.
    Kruglov EA, Nathanson RA, Nguyen T, Dranoff JA. Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts. Am J Physiol Gastrointest Liver Physiol. 2006;290(4):G765–71.PubMedGoogle Scholar
  205. 205.
    Omenetti A, Yang L, Li YX, et al. Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation. Lab Invest. 2007;87(5):499–514.PubMedGoogle Scholar
  206. 206.
    Lesage GD, Marucci L, Alvaro D, et al. Insulin inhibits secretin-induced ductal secretion by activation of PKC alpha and inhibition of PKA activity. Hepatology. 2002;36(3):641–51.PubMedGoogle Scholar
  207. 207.
    LeCouter J, Moritz DR, Li B, et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science. 2003;299(5608):890–3.PubMedGoogle Scholar
  208. 208.
    Gaudio E, Onori P, Pannarale L, Alvaro D. Hepatic microcirculation and peribiliary plexus in experimental biliary cirrhosis: a morphological study. Gastroenterology. 1996;111(4):1118–24.PubMedGoogle Scholar
  209. 209.
    Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest. 2009;119(6):1438–49.PubMedGoogle Scholar
  210. 210.
    Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008;10(5):593–601.PubMedGoogle Scholar
  211. 211.
    Diaz R, Kim JW, Hui JJ, et al. Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. Hum Pathol. 2008;39(1):102–15.PubMedGoogle Scholar
  212. 212.
    Robertson H, Kirby JA, Yip WW, Jones DE, Burt AD. Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis. Hepatology. 2007;45(4):977–81.PubMedGoogle Scholar
  213. 213.
    Rygiel KA, Robertson H, Marshall HL, et al. Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab Invest. 2008;88(2):112–23.PubMedGoogle Scholar
  214. 214.
    Montminy M. Transcriptional regulation by cyclic AMP. Annu Rev Biochem. 1997;66:807–22.PubMedGoogle Scholar
  215. 215.
    LeSag EG, Alvaro D, Benedetti A, et al. Cholinergic system modulates growth, apoptosis, and secretion of cholangiocytes from bile duct-ligated rats. Gastroenterology. 1999;117(1):191–9.Google Scholar
  216. 216.
    Francis H, Glaser S, Ueno Y, et al. cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway. J Hepatol. 2004;41(4):528–37.PubMedGoogle Scholar
  217. 217.
    Glaser S, Alvaro D, Francis H, et al. Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt. Am J Physiol Gastrointest Liver Physiol. 2006;290(4):G813–26.PubMedGoogle Scholar
  218. 218.
    Marzioni M, Glaser S, Francis H, et al. Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. Gastroenterology. 2005;128(1):121–37.PubMedGoogle Scholar
  219. 219.
    Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev. 2004;68(2):320–44.PubMedGoogle Scholar
  220. 220.
    Komalavilas P, Lincoln TM. Phosphorylation of the inositol 1, 4, 5-trisphosphate receptor. Cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta. J Biol Chem. 1996;271(36):21933–8.PubMedGoogle Scholar
  221. 221.
    Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296(5573):1655–7.PubMedGoogle Scholar
  222. 222.
    Strazzabosco M, Fiorotto R, Melero S, et al. Differentially expressed adenylyl cyclase isoforms mediate secretory functions in cholangiocyte subpopulation. Hepatology. 2009;50(1):244–52.PubMedGoogle Scholar
  223. 223.
    Marzioni M, Francis H, Benedetti A, et al. Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts. Am J Pathol. 2006;168(2):398–409.PubMedGoogle Scholar
  224. 224.
    Alpini G, Glaser S, Francis H, et al. Bile acid interaction with cholangiocytes. In: Alpini G, Alvaro D, LeSage G, Marzioni M, LaRusso N, editors. The pathophysiology of biliary epithelia. Georgetown, TX: Landes Biosciences; 2004. p. 112–22.Google Scholar
  225. 225.
    Shibao K, Hirata K, Robert ME, Nathanson MH. Loss of inositol 1, 4, 5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis. Gastroenterology. 2003;125(4):1175–87.PubMedGoogle Scholar
  226. 226.
    Hernandez E, Nathanson M. Calcium signaling in cholangiocytes. In: Alpini G, Alvaro D, LeSage G, Marzioni M, LaRusso N, editors. The pathophysiology of biliary epithelia. Georgetown, TX: Landes Biosciences; 2004.Google Scholar
  227. 227.
    Joseph SK. The inositol triphosphate receptor family. Cell Signal. 1996;8(1):1–7.PubMedGoogle Scholar
  228. 228.
    Glaser S, Benedetti A, Marucci L, et al. Gastrin inhibits cholangiocyte growth in bile duct-ligated rats by interaction with cholecystokinin-B/Gastrin receptors via D-myo-inositol 1, 4, 5-triphosphate-, Ca(2+)-, and protein kinase C alpha-dependent mechanisms. Hepatology. 2000;32(1):17–25.PubMedGoogle Scholar
  229. 229.
    Stella MC, Comoglio PM. HGF: a multifunctional growth factor controlling cell scattering. Int J Biochem Cell Biol. 1999;31(12):1357–62.PubMedGoogle Scholar
  230. 230.
    Park J, Gores GJ, Patel T. Lipopolysaccharide induces cholangiocyte proliferation via an interleukin-6-mediated activation of p44/p42 mitogen-activated protein kinase. Hepatology. 1999;29(4):1037–43.PubMedGoogle Scholar
  231. 231.
    Hynes NE, Horsch K, Olayioye MA, Badache A. The ErbB receptor tyrosine family as signal integrators. Endocr Relat Cancer. 2001;8(3):151–9.PubMedGoogle Scholar
  232. 232.
    Bajorath J. Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions. Proteins. 2000;39(2):103–11.PubMedGoogle Scholar
  233. 233.
    Bartolazzi A, Nocks A, Aruffo A, Spring F, Stamenkovic I. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol. 1996;132(6):1199–208.PubMedGoogle Scholar
  234. 234.
    He Y, Wu GD, Sadahiro T, et al. Interaction of CD44 and hyaluronic acid enhances biliary epithelial proliferation in cholestatic livers. Am J Physiol Gastrointest Liver Physiol. 2008;295(2):G305–12.PubMedGoogle Scholar
  235. 235.
    Mikami T, Saegusa M, Mitomi H, Yanagisawa N, Ichinoe M, Okayasu I. Significant correlations of E-cadherin, catenin, and CD44 variant form expression with carcinoma cell differentiation and prognosis of extrahepatic bile duct carcinomas. Am J Clin Pathol. 2001;116(3):369–76.PubMedGoogle Scholar
  236. 236.
    Xu B, Broome U, Ericzon BG, Sumitran-Holgersson S. High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6. Gut. 2002;51(1):120–7.PubMedGoogle Scholar
  237. 237.
    Corpechot C, Carrat F, Poupon R, Poupon RE. Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients. Gastroenterology. 2002;122(3):652–8.PubMedGoogle Scholar
  238. 238.
    Alpini G, Baiocchi L, Glaser S, et al. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha. Hepatology. 2002;35(5):1041–52.PubMedGoogle Scholar
  239. 239.
    Poo JL, Feldmann G, Erlinger S, et al. Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat. Gastroenterology. 1992;102(5):1752–9.PubMedGoogle Scholar
  240. 240.
    Alpini G, Glaser S, Robertson W, et al. Bile acids stimulate proliferative and secretory events in large but not small cholangiocytes. Am J Physiol. 1997;273(2 Pt 1):G518–29.PubMedGoogle Scholar
  241. 241.
    Alpini G, Ueno Y, Glaser SS, et al. Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes. Hepatology. 2001;34(5):868–76.PubMedGoogle Scholar
  242. 242.
    Tan CK, Podila PV, Taylor JE, et al. Human cholangiocarcinomas express somatostatin receptors and respond to somatostatin with growth inhibition. Gastroenterology. 1995;108(6):1908–16.PubMedGoogle Scholar
  243. 243.
    Tracy Jr TF, Tector AJ, Goerke ME, Kitchen S, Lagunoff D. Somatostatin analogue (octreotide) inhibits bile duct epithelial cell proliferation and fibrosis after extrahepatic biliary obstruction. Am J Pathol. 1993;143(6):1574–8.PubMedGoogle Scholar
  244. 244.
    Masyuk TV, Masyuk AI, Torres VE, Harris PC, Larusso NF. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3′, 5′-cyclic monophosphate. Gastroenterology. 2007;132(3):1104–16.PubMedGoogle Scholar
  245. 245.
    Glaser S, Alvaro D, Ueno Y, et al. Gastrin reverses established cholangiocyte proliferation and enhanced secretin-stimulated ductal secretion of BDL rats by activation of apoptosis through increased expression of Ca2+- dependent PKC isoforms. Liver Int. 2003;23(2):78–88.PubMedGoogle Scholar
  246. 246.
    Kanno N, Glaser S, Chowdhury U, et al. Gastrin inhibits cholangiocarcinoma growth through increased apoptosis by activation of Ca2+-dependent protein kinase C-alpha. J Hepatol. 2001;34(2):284–91.PubMedGoogle Scholar
  247. 247.
    Marzioni M, Alpini G, Saccomanno S, et al. Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis. Gastroenterology. 2007;133(1):244–55.PubMedGoogle Scholar
  248. 248.
    Masyuk T, Masyuk A, LaRusso N. Cholangiociliopathies: genetics, molecular mechanisms and potential therapies. Curr Opin Gastroenterol. 2009;25(3):265–71.PubMedGoogle Scholar
  249. 249.
    Alvaro D, Mancino MG, Onori P, et al. Estrogens and the pathophysiology of the biliary tree. World J Gastroenterol. 2006;12(22):3537–45.PubMedGoogle Scholar
  250. 250.
    Alvaro D, Alpini G, Onori P, et al. Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats. Gastroenterology. 2000;119(6):1681–91.PubMedGoogle Scholar
  251. 251.
    Alvaro D, Onori P, Metalli VD, et al. Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. Hepatology. 2002;36(2):297–304.PubMedGoogle Scholar
  252. 252.
    Alvaro D, Alpini G, Onori P, et al. Effect of ovariectomy on the proliferative capacity of intrahepatic rat cholangiocytes. Gastroenterology. 2002;123(1):336–44.PubMedGoogle Scholar
  253. 253.
    Glaser S, DeMorrow S, Francis H, et al. Progesterone stimulates the proliferation of female and male cholangiocytes via autocrine/paracrine mechanisms. Am J Physiol Gastrointest Liver Physiol. 2008;295(1):G124–G36.PubMedGoogle Scholar
  254. 254.
    Mancinelli R, Onori P, Gaudio E, et al. Follicle-stimulating hormone increases cholangiocyte proliferation by an autocrine mechanism via cAMP-dependent phosphorylation of ERK1/2 and Elk-1. Am J Physiol Gastrointest Liver Physiol. 2009;297(1):G11–26.PubMedGoogle Scholar
  255. 255.
    Taffetani S, Glaser S, Francis H, et al. Prolactin stimulates the proliferation of normal female cholangiocytes by differential regulation of Ca2+-dependent PKC isoforms. BMC Physiol. 2007;7:6.PubMedGoogle Scholar
  256. 256.
    Fava G, Ueno Y, Glaser S, et al. Thyroid hormone inhibits biliary growth in bile duct-ligated rats by PLC/IP(3)/Ca(2+)-dependent downregulation of SRC/ERK1/2. Am J Physiol Cell Physiol. 2007;292(4):C1467–75.PubMedGoogle Scholar
  257. 257.
    Marzioni M, Ueno Y, Glaser S, et al. Cytoprotective effects of taurocholic acid feeding on the biliary tree after adrenergic denervation of the liver. Liver Int. 2007;27(4):558–68.PubMedGoogle Scholar
  258. 258.
    Gigliozzi A, Alpini G, Baroni GS, et al. Nerve growth factor modulates the proliferative capacity of the intrahepatic biliary epithelium in experimental cholestasis. Gastroenterology. 2004;127(4):1198–209.PubMedGoogle Scholar
  259. 259.
    Glaser SS, Gaudio E, Miller T, Alvaro D, Alpini G. Cholangiocyte proliferation and liver fibrosis. Expert Rev Mol Med. 2009;11:e7.PubMedGoogle Scholar
  260. 260.
    Francis H, Franchitto A, Ueno Y, et al. H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. Lab Invest. 2007;87(5):473–87.PubMedGoogle Scholar
  261. 261.
    Francis H, Glaser S, Demorrow S, et al. Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway. Am J Physiol Cell Physiol. 2008;295(2):C499–513.PubMedGoogle Scholar
  262. 262.
    Glaser SS, Ueno Y, DeMorrow S, et al. Knockout of alpha-calcitonin gene-related peptide reduces cholangiocyte proliferation in bile duct ligated mice. Lab Invest. 2007;87(9):914–26.PubMedGoogle Scholar
  263. 263.
    Gaudio E, Barbaro B, Alvaro D, et al. Administration of r-VEGF-A prevents hepatic artery ligation-induced bile duct damage in bile duct ligated rats. Am J Physiol Gastrointest Liver Physiol. 2006;291(2):G307–17.PubMedGoogle Scholar
  264. 264.
    Lamireau T, Zoltowska M, Levy E, et al. Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion. Life Sci. 2003;72(12):1401–11.PubMedGoogle Scholar
  265. 265.
    Liu Z, Sakamoto T, Ezure T, et al. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium. Hepatology. 1998;28(5):1260–8.PubMedGoogle Scholar
  266. 266.
    Liu Z, Sakamoto T, Yokomuro S, et al. Acute obstructive cholangiopathy in interleukin-6 deficient mice: compensation by leukemia inhibitory factor (LIF) suggests importance of gp-130 signaling in the ductular reaction. Liver. 2000;20(2):114–24.PubMedGoogle Scholar
  267. 267.
    Rosen HR, Winkle PJ, Kendall BJ, Diehl DL. Biliary interleukin-6 and tumor necrosis factor-alpha in patients undergoing endoscopic retrograde cholangiopancreatography. Dig Dis Sci. 1997;42(6):1290–4.PubMedGoogle Scholar
  268. 268.
    Scotte M, Daveau M, Hiron M, et al. Interleukin-6 (IL-6) and acute-phase proteins in rats with biliary sepsis. Eur Cytokine Netw. 1991;2(3):177–82.PubMedGoogle Scholar
  269. 269.
    Kimmings AN, van Deventer SJ, Obertop H, Rauws EA, Huibregtse K, Gouma DJ. Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut. 2000;46(5):725–31.PubMedGoogle Scholar
  270. 270.
    Akiyama T, Hasegawa T, Sejima T, et al. Serum and bile interleukin 6 after percutaneous transhepatic cholangio-drainage. Hepatogastroenterology. 1998;45(21):665–71.PubMedGoogle Scholar
  271. 271.
    Lin ZQ, Kondo T, Ishida Y, Takayasu T, Mukaida N. Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. J Leukoc Biol. 2003;73(6):713–21.PubMedGoogle Scholar
  272. 272.
    Gallucci RM, Simeonova PP, Matheson JM, et al. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J. 2000;14(15):2525–31.PubMedGoogle Scholar
  273. 273.
    Ezure T, Sakamoto T, Tsuji H, et al. The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am J Pathol. 2000;156(5):1627–39.PubMedGoogle Scholar
  274. 274.
    Yokomuro S, Tsuji H, Lunz 3rd JG, et al. Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells. Hepatology. 2000;32(1):26–35.PubMedGoogle Scholar
  275. 275.
    Strain AJ, Wallace L, Joplin R, et al. Characterization of biliary epithelial cells isolated from needle biopsies of human liver in the presence of hepatocyte growth factor. Am J Pathol. 1995;146(2):537–45.PubMedGoogle Scholar
  276. 276.
    Joplin R, Hishida T, Tsubouchi H, et al. Human intrahepatic biliary epithelial cells proliferate in vitro in response to human hepatocyte growth factor. J Clin Invest. 1992;90(4):1284–9.PubMedGoogle Scholar
  277. 277.
    Appasamy R, Tanabe M, Murase N, et al. Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats. Lab Invest. 1993;68(3):270–6.PubMedGoogle Scholar
  278. 278.
    Schirmacher P, Geerts A, Pietrangelo A, Dienes HP, Rogler CE. Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology. 1992;15(1):5–11.PubMedGoogle Scholar
  279. 279.
    Endo K, Yoon BI, Pairojkul C, Demetris AJ, Sirica AE. ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions. Hepatology. 2002;36(2):439–50.PubMedGoogle Scholar
  280. 280.
    Napoli J, Prentice D, Niinami C, Bishop GA, Desmond P, McCaughan GW. Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis. Hepatology. 1997;26(3):624–33.PubMedGoogle Scholar
  281. 281.
    Kaido T, Yamaoka S, Seto S, et al. Continuous hepatocyte growth factor supply prevents lipopolysaccharide-induced liver injury in rats. FEBS Lett. 1997;411(2–3):378–82.PubMedGoogle Scholar
  282. 282.
    Matsuda Y, Matsumoto K, Yamada A, et al. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology. 1997;26(1):81–9.PubMedGoogle Scholar
  283. 283.
    Ueki T, Kaneda Y, Tsutsui H, et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med. 1999;5(2):226–30.PubMedGoogle Scholar
  284. 284.
    Russell W, Carver R. The EGF/TGFa family of growth factors and their receptors. In: Strain A, Diehl A, editors. Liver Growth and REpair. London, UK: Chapman & Hall; 1998. p. 185–218.Google Scholar
  285. 285.
    Harada K, Terada T, Nakanuma Y. Detection of transforming growth factor-alpha protein and messenger RNA in hepatobiliary diseases by immunohistochemical and in situ hybridization techniques. Hum Pathol. 1996;27(8):787–92.PubMedGoogle Scholar
  286. 286.
    Ishii M, Vroman B, LaRusso NF. Morphologic demonstration of receptor-mediated endocytosis of epidermal growth factor by isolated bile duct epithelial cells. Gastroenterology. 1990;98(5 Pt 1):1284–91.PubMedGoogle Scholar
  287. 287.
    Sirica AE, Gainey TW. A new rat bile ductular epithelial cell culture model characterized by the appearance of polarized bile ducts in vitro. Hepatology. 1997;26(3):537–49.PubMedGoogle Scholar
  288. 288.
    Plebani M, Panozzo MP, Basso D, De Paoli M, Biasin R, Infantolino D. Cytokines and the progression of liver damage in experimental bile duct ligation. Clin Exp Pharmacol Physiol. 1999;26(4):358–63.PubMedGoogle Scholar
  289. 289.
    Oguey D, Marti U, Reichen J. Epidermal growth factor receptor in chronic bile duct obstructed rats: implications for maintenance of hepatocellular mass. Eur J Cell Biol. 1992;59(1):187–95.PubMedGoogle Scholar
  290. 290.
    Reindel JF, Pilcher GD, Gough AW, Haskins JR, de la Iglesia FA. Recombinant human epidermal growth factor1–48-induced structural changes in the digestive tract of cynomolgus monkeys (Macaca fascicularis). Toxicol Pathol. 1996;24(6):669–80.PubMedGoogle Scholar
  291. 291.
    Hayashi N, Yamamoto H, Hiraoka N, et al. Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm. Hepatology. 2001;34(4 Pt 1):638–50.PubMedGoogle Scholar
  292. 292.
    Chariyalertsak S, Sirikulchayanonta V, Mayer D, et al. Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma. Gut. 2001;48(1):80–6.PubMedGoogle Scholar
  293. 293.
    Vadlamudi R, Mandal M, Adam L, Steinbach G, Mendelsohn J, Kumar R. Regulation of cyclooxygenase-2 pathway by HER2 receptor. Oncogene. 1999;18(2):305–14.PubMedGoogle Scholar
  294. 294.
    Kiguchi K, Carbajal S, Chan K, et al. Constitutive expression of ErbB-2 in gallbladder epithelium results in development of adenocarcinoma. Cancer Res. 2001;61(19):6971–6.Google Scholar
  295. 295.
    Pawliczak R, Han C, Huang XL, Demetris AJ, Shelhamer JH, Wu T. 85-kDa cytosolic phospholipase A2 mediates peroxisome proliferator-activated receptor gamma activation in human lung epithelial cells. J Biol Chem. 2002;277(36):33153–63.PubMedGoogle Scholar
  296. 296.
    Wirth K, Mertelsmann R. Cytoprotective function of keratinocyte growth factor in tumour therapy-induced tissue damage. Br J Haematol. 2002;116(3):505–10.PubMedGoogle Scholar
  297. 297.
    Nguyen HQ, Danilenko DM, Bucay N, et al. Expression of keratinocyte growth factor in embryonic liver of transgenic mice causes changes in epithelial growth and differentiation resulting in polycystic kidneys and other organ malformations. Oncogene. 1996;12(10):2109–19.PubMedGoogle Scholar
  298. 298.
    de Groen PC, Vroman B, Laakso K, LaRusso NF. Characterization and growth regulation of a rat intrahepatic bile duct epithelial cell line under hormonally defined, serum-free conditions. In Vitro Cell Dev Biol Anim. 1998;34(9):704–10.PubMedGoogle Scholar
  299. 299.
    Nakatsukasa H, Nagy P, Evarts RP, Hsia CC, Marsden E, Thorgeirsson SS. Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest. 1990;85(6):1833–43.PubMedGoogle Scholar
  300. 300.
    Saperstein LA, Jirtle RL, Farouk M, Thompson HJ, Chung KS, Meyers WC. Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat. Hepatology. 1994;19(2):412–7.PubMedGoogle Scholar
  301. 301.
    Milani S, Herbst H, Schuppan D, Stein H, Surrenti C. Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol. 1991;139(6):1221–9.PubMedGoogle Scholar
  302. 302.
    De Bleser PJ, Niki T, Xu G, Rogiers V, Geerts A. Localization and cellular sources of activins in normal and fibrotic rat liver. Hepatology. 1997;26(4):905–12.PubMedGoogle Scholar
  303. 303.
    Tan CE, Chan VS, Yong RY, et al. Distortion in TGF beta 1 peptide immunolocalization in biliary atresia: comparison with the normal pattern in the developing human intrahepatic bile duct system. Pathol Int. 1995;45(11):815–24.PubMedGoogle Scholar
  304. 304.
    Miyazaki M, Ohashi R, Tsuji T, Mihara K, Gohda E, Namba M. Transforming growth factor-beta 1 stimulates or inhibits cell growth via down- or up-regulation of p21/Waf1. Biochem Biophys Res Commun. 1998;246(3):873–80.PubMedGoogle Scholar
  305. 305.
    Demetris A, Adams D, Bellamy C, et al. Update of the Interna tional Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology. 2000;31(3):792–9.PubMedGoogle Scholar
  306. 306.
    Lunz 3rd JG, Tsuji H, Nozaki I, Murase N, Demetris AJ. An inhibitor of cyclin-dependent kinase, stress-induced p21Waf-1/Cip-1, mediates hepatocyte mito-inhibition during the evolution of cirrhosis. Hepatology. 2005;41(6):1262–71.PubMedGoogle Scholar
  307. 307.
    Ito Y, Takeda T, Sakon M, Monden M, Tsujimoto M, Matsuura N. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct. Anticancer Res. 2000;20(1A):337–44.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Yoshiaki Mizuguchi
  • Susan Specht
  • Kumiko Isse
  • John G. LunzIII
  • Anthony J. Demetris
    • 1
  1. 1.Department of PathologyThomas E. Starzl Transplantation InstitutePittsburghUSA

Personalised recommendations